Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Registry Study Designed to Collect Real-world Hemodynamic and Clinical Outcomes of the INSPIRIS RESILIA Aortic Valve

NCT07120048 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT07120048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07120048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Registry Study Designed to Collect Real-world Hemodynamic and Clinical Outcomes of the INSPIRIS RESILIA Aortic Valve
Lead sponsor
Edwards Lifesciences
Phase
Observational
Overall status
Recruiting
Start date
July 30, 2025
Completion date
December 31, 2026
Enrollment
500 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease